IONIS PHARMACEUTICALS INC Logo

IONIS PHARMACEUTICALS INC

A leader in antisense technology, developing RNA-targeted drugs for neurology and cardiology.

IONS | US

Overview

Corporate Details

ISIN(s):
US4622221004
LEI:
Country:
United States of America
Address:
2855 GAZELLE COURT, 92010 CARLSBAD
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ionis Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing RNA-targeted therapeutics. A leader in antisense technology, the company utilizes its proprietary science and chemistry platform to create medicines that treat a wide range of serious diseases. Ionis maintains a robust pipeline and has several marketed products targeting conditions in neurology, cardiology, and other areas of high unmet patient need. The company's core mission is to leverage its deep understanding of genetics to deliver innovative treatments that can change the course of human health for patients and their families.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IONIS PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IONIS PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IONIS PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NIPPON CHEMIPHAR CO., LTD. Logo
Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.
Japan 4539
Nippon Shinyaku Co.,Ltd. Logo
Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.
Japan 4516
Nkarta, Inc. Logo
Developing off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America NKTX
NKMAX Co., Ltd. Logo
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea 182400
NLS Pharmaceutics Ltd. Logo
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America NLSP
NovaBay Pharmaceuticals, Inc. Logo
Develops clinically-proven anti-infective therapies for eyecare, skincare, and wound care.
United States of America NBY
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland NOVN
NOVAVAX INC Logo
Develops and commercializes nanoparticle vaccines for serious infectious diseases.
United States of America NVAX
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea 229500

Talk to a Data Expert

Have a question? We'll get back to you promptly.